BCLI
NASDAQ
$0.95
Brainstorm Cell Therapeutics Inc (BCLI)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$11M
Free Cash Flow Yield
-62.09%
Price Chart
Valuation
Market Cap$11M
Profitability
EBITDA-$8.73M
EPS-$0.89
Financial Health
Debt-to-Equity-12.1%
Free Cash Flow Yield-62.09%
Growth & Risk
EPS 5Y CAGR-42.07%
FCF 5Y CAGR-25.75%
Sharpe Ratio0.18